NO173544C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2- tiometyl-substituerte 1,4-dihydropyridiner - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2- tiometyl-substituerte 1,4-dihydropyridiner

Info

Publication number
NO173544C
NO173544C NO871445A NO871445A NO173544C NO 173544 C NO173544 C NO 173544C NO 871445 A NO871445 A NO 871445A NO 871445 A NO871445 A NO 871445A NO 173544 C NO173544 C NO 173544C
Authority
NO
Norway
Prior art keywords
dihydropyridines
thiomethyl
substituted
preparation
therapeutically active
Prior art date
Application number
NO871445A
Other languages
English (en)
Norwegian (no)
Other versions
NO173544B (no
NO871445L (no
NO871445D0 (no
Inventor
A Carmelo Gandolfi
Marco Frigerio
Silvano Spinnelli
Odoardo Tofanetti
Sergio Togonella
Original Assignee
Boehringer Mannheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT8521876A external-priority patent/IT1215299B/it
Priority claimed from IT20966/86A external-priority patent/IT1204422B/it
Priority claimed from IT20965/86A external-priority patent/IT1204421B/it
Application filed by Boehringer Mannheim Italia filed Critical Boehringer Mannheim Italia
Publication of NO871445D0 publication Critical patent/NO871445D0/no
Publication of NO871445L publication Critical patent/NO871445L/no
Publication of NO173544B publication Critical patent/NO173544B/no
Publication of NO173544C publication Critical patent/NO173544C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO871445A 1985-08-06 1987-04-06 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2- tiometyl-substituerte 1,4-dihydropyridiner NO173544C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT8521876A IT1215299B (it) 1985-08-06 1985-08-06 Diidropiridine 2-tiosostituite, metodo per la loro preparazione e composizione farmaceutiche che le contengono.
IT20966/86A IT1204422B (it) 1986-06-27 1986-06-27 2-((alchilsostituite) tio) metil-1,4-diidropiridine,processo per la loro preparazione e composizioni che le contengono
IT20965/86A IT1204421B (it) 1986-06-27 1986-06-27 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono
PCT/EP1986/000445 WO1987000836A1 (en) 1985-08-06 1986-07-29 Pharmaceutically active 2-thiomethyl-substituted-1,4-dihydropyridines

Publications (4)

Publication Number Publication Date
NO871445D0 NO871445D0 (no) 1987-04-06
NO871445L NO871445L (no) 1987-06-05
NO173544B NO173544B (no) 1993-09-20
NO173544C true NO173544C (no) 1993-12-29

Family

ID=27273117

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871445A NO173544C (no) 1985-08-06 1987-04-06 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2- tiometyl-substituerte 1,4-dihydropyridiner

Country Status (14)

Country Link
US (2) US4999362A (zh)
EP (1) EP0233228A1 (zh)
KR (1) KR930011486B1 (zh)
CN (1) CN86106242A (zh)
AU (1) AU593278B2 (zh)
DK (1) DK175487D0 (zh)
ES (1) ES2009136A6 (zh)
FI (1) FI92194C (zh)
HU (1) HU199796B (zh)
IE (1) IE862066L (zh)
IL (1) IL79572A0 (zh)
NO (1) NO173544C (zh)
PT (1) PT83143B (zh)
WO (1) WO1987000836A1 (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137889A (en) * 1983-12-02 1992-08-11 Otsuka Pharmaceutical Co., Ltd. Dihydropyridine derivatives and process for preparing the same
GB8601382D0 (en) * 1986-01-21 1986-02-26 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
IT1204421B (it) * 1986-06-27 1989-03-01 Boehringer Biochemia Srl 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
NO874194L (no) * 1986-11-07 1988-05-09 Pfizer Ltd Fremgangsmaate ved fremstilling av dihydro-pyridinderivater
US4723014A (en) * 1986-11-19 1988-02-02 Warner-Lambert Company Process for the preparation of 2-substituted-1,4-dihydropyridines
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
IT1215381B (it) * 1987-03-12 1990-02-08 Boehringer Biochemia Srl Farmaceutiche che le contengono. carbonil- e solfonil- derivati di 2-(aminoalchiltio)metil-1,4-diidropiridine, un metodo per la loro preparazione e composizioni
IT1205114B (it) * 1987-05-29 1989-03-15 Boehringer Biochemia Srl 2-selenometil-1,4-diidropiridine,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1230752B (it) * 1989-02-17 1991-10-29 Boehringer Biochemia Srl Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.
IT1249210B (it) * 1990-06-08 1995-02-20 Boehringer Mannheim Italia ¬3h,7h| tiazolo-¬3,4-a| piridine ad attivita' antiasmatica e antiinfiammatoria delle vie aeree
IT1252626B (it) * 1991-12-06 1995-06-19 Boehringer Mannheim Italia ¬3h, 7h| tiazolo ¬3,4a| piridine ad attivita' antiasmatica ed antiinfiammatoria delle vie aeree
IT1252627B (it) * 1991-12-06 1995-06-19 Boehringer Mannehim Italia S P ¬3h,7h| tiazolo ¬3,4-a| piridine ad attivita' antiasmatica e antiinfiammatoria delle vie aeree
JPH0770083A (ja) * 1993-07-05 1995-03-14 Nippon Chemiphar Co Ltd イミダゾール誘導体を有効成分とする血圧降下剤
US5576439A (en) * 1994-10-28 1996-11-19 Ciba-Geigy Corporation Dihydropyridinecarboxylic acid anhydrides
AU5568300A (en) 1999-06-23 2001-01-09 Ajinomoto Co., Inc. Novel dihydropyridine derivative
ES2177409B1 (es) * 2000-08-02 2003-08-01 Liconsa Liberacion Controlada Procedimiento para la obtencion de 1,4-dihidropiridinas substituida utiles para el tratamiento de la hipertension.
ITMI20031333A1 (it) * 2003-06-30 2005-01-01 Erregierre Spa Processo di preparazione di raloxifene cloridrato.
WO2006042161A2 (en) 2004-10-07 2006-04-20 E.I. Dupont De Nemours And Company Polysaccharide-based polymer tissue adhesive for medical use
AR056815A1 (es) * 2005-11-18 2007-10-24 Synthon Bv PROCESO PARA PREPARAR MONTELUKAST, INTERMEDIARIOS DEL MISMO Y SUS SALES DE ADICIoN Y PROCEDIMIENTO DE PURIFICACIoN DE ÉSTOS Y DE MONTELUKAST
CA2632212A1 (en) * 2005-12-07 2007-06-14 American Diagnostica Inc. Plasminogen activator inhibitor-1 inhibitors
CN101541857B (zh) 2006-11-27 2012-12-12 阿克塔马克斯手术器材有限责任公司 多官能聚环氧烷、水凝胶和组织粘合剂
EP2214731B1 (en) 2007-11-14 2014-05-14 Actamax Surgical Materials LLC Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
US8551136B2 (en) 2008-07-17 2013-10-08 Actamax Surgical Materials, Llc High swell, long-lived hydrogel sealant
EP2349357B1 (en) 2008-11-19 2012-10-03 Actamax Surgical Materials LLC Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether
US8466327B2 (en) 2008-11-19 2013-06-18 Actamax Surgical Materials, Llc Aldehyde-functionalized polyethers and method of making same
EP2416811B1 (en) 2009-04-09 2015-09-09 Actamax Surgical Materials LLC Hydrogel tissue adhesive having reduced degradation time
US8580951B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US8580950B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US8859705B2 (en) 2012-11-19 2014-10-14 Actamax Surgical Materials Llc Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
WO2015017340A2 (en) 2013-07-29 2015-02-05 Actamax Surgical Materials, Llc Low swell tissue adhesive and sealant formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
IL68604A0 (en) * 1982-05-21 1983-09-30 Haessle Ab Processes for preparing therapeutically active dihydropyridines and intermediates for the processes
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
US4686217A (en) * 1983-04-27 1987-08-11 Fisons Plc Calcium antagonist 2-fluoroalkyl-1,4-dihydropyridines
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents
GB8401288D0 (en) * 1984-01-18 1984-02-22 Pfizer Ltd Therapeutic agents
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
DE3567460D1 (en) * 1984-06-07 1989-02-16 Pfizer Ltd Dihydropyridines
EP0200524A3 (en) * 1985-05-03 1987-06-16 Pfizer Limited Dihydropyridine calcium antagonists
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.

Also Published As

Publication number Publication date
FI871492A0 (fi) 1987-04-06
NO173544B (no) 1993-09-20
AU593278B2 (en) 1990-02-08
FI92194B (fi) 1994-06-30
HU199796B (en) 1990-03-28
KR870700604A (ko) 1987-12-30
US5021436A (en) 1991-06-04
NO871445L (no) 1987-06-05
AU6224586A (en) 1987-03-05
DK175487A (da) 1987-04-06
DK175487D0 (da) 1987-04-06
CN86106242A (zh) 1987-05-13
ES2009136A6 (es) 1989-09-01
PT83143B (pt) 1988-07-29
FI871492A (fi) 1987-04-06
NO871445D0 (no) 1987-04-06
PT83143A (en) 1986-09-01
IL79572A0 (en) 1986-10-31
US4999362A (en) 1991-03-12
WO1987000836A1 (en) 1987-02-12
FI92194C (fi) 1994-10-10
EP0233228A1 (en) 1987-08-26
KR930011486B1 (ko) 1993-12-08
HUT44499A (en) 1988-03-28
IE862066L (en) 1987-02-06

Similar Documents

Publication Publication Date Title
NO173544C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2- tiometyl-substituerte 1,4-dihydropyridiner
NO170483C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrahydronaftalin- og indanderivater
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO170884C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO173653C (no) Analogifremgangsmaate for fresmstilling av terapeutisk aktive 6-benzoksazinyl-og 6-benzotianzinyl-2,3,4,5-tetrahydropyridazin-3-oner
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO864110D0 (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO167912C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aromatiske forbindelser
NO178069C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive platinakomplekser
NO168107C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
FI871087A (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO173503C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner
NO177096C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner
NO862141L (no) Fremgangsmaate for fremstilling av aktive cinnolinderivater
NO166127C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte difenylpiperidiner.
NO874194D0 (no) Fremgangsmaate ved fremstilling av dihydro-pyridinderivater
NO168706C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.